QC
TMCI icon

Quadrature Capital’s Treace Medical Concepts TMCI Stock Holding History

Quadrature Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Sell
25,809
-6,743
-21% -$18.5K ﹤0.01% 1461
2026
Q1 		$43.6K Sell
32,552
-28,092
-46% -$56K ﹤0.01% 1287
2025
Q4 		$149K Buy
+60,644
New +$263K ﹤0.01% 1030

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Quadrature Capital's TMCI Position: Q2 2026 in Review

Quadrature Capital reduced its Treace Medical Concepts (TMCI) stake by 21% in Q2 2026, selling an estimated $18.5K and leaving 25,809 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1461.

Quadrature Capital first reported a position in TMCI in Q4 2025 and has held it in 3 quarters since. The position peaked at $149K in Q4 2025. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Quadrature Capital held 25,809 shares of Treace Medical Concepts worth $103K as of Q2 2026.
  • Quadrature Capital sold 6,743 Treace Medical Concepts shares in Q2 2026, an estimated $18.5K.
  • Treace Medical Concepts made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1461 holding.
  • Quadrature Capital first reported a position in Treace Medical Concepts in Q4 2025 and has held it in 3 quarters since.
  • Quadrature Capital's Treace Medical Concepts position peaked at $149K in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.